Oyster Point Pharma announced it will implement an operating expense streamlining plan that will include a reduction of employee and non-employee expenses across the organization.
Notal Vision reported that scientific and clinical publications and presentations demonstrate the feasibility and efficacy of their patient-operated, home-based optical coherence tomography (OCT) device.
BRIM Biotechnology has entered OTC trading in Taiwan on June 23, 2022. Established in 2013, BRIM is a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases.
Optical laboratory owners and operators from around the globe gathered last week at Digicon 2022, a conference sponsored by Schneider Optical Machines that served as a springboard to launch Modulo One, the company’s fully automated platform.
The American Academy of Optometry Foundation is a nonprofit, philanthropic organization that develops and provides financial support for optometric research and education in vision and eye health to improve clinical care.
ORLANDO, Fla.—Lensar, Inc. (NASDAQ: LNSR), based here, announced that it has received U.S. Food and Drug Administration 510(k) clearance for its next-generation ALLY Adaptive Cataract Treatment System.
Nacuity Pharmaceuticals announced the closing of a $16.5 million Series B financing led by Foundation Fighting Blindness and its venture arm RD Fund. Additional existing investors also participated in the round.
Vyluma and Laboratoires Théa announced that they have recently entered into an exclusive licensing agreement for the registration and commercialization of NVK002 in Canada, Mexico, and select South American Countries.
Samsara Vision has formed a collaboration with Lansheng Medical “MyVision,” to develop a clinical and commercial organization to support Samsara Vision’s SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) in China.
Rayner announced that it has entered into a commercial partnership and concurrently acquired a stake in Hasa Optix, a Brussels-based manufacturer of single use ophthalmic surgical instruments and instrument sets.